DBMZX
Price
$29.96
Change
+$0.05 (+0.17%)
Updated
Jan 17 closing price
Net Assets
1.26B
PEMGX
Price
$43.55
Change
+$0.27 (+0.62%)
Updated
Jan 17 closing price
Net Assets
29.35B
Ad is loading...

DBMZX vs PEMGX

Header iconDBMZX vs PEMGX Comparison
Open Charts DBMZX vs PEMGXBanner chart's image
BNY Mellon Sm/Md Cp Gr Z
Price$29.96
Change+$0.05 (+0.17%)
VolumeN/A
Net Assets1.26B
Principal MidCap A
Price$43.55
Change+$0.27 (+0.62%)
VolumeN/A
Net Assets29.35B
DBMZX vs PEMGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DBMZX vs. PEMGX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBMZX is a Buy and PEMGX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
PEMGX has more cash in the bank: 29.3B vs. DBMZX (1.26B). DBMZX (0.00) and PEMGX (0.00) have matching dividends . DBMZX was incepted earlier than PEMGX: DBMZX (7 years) vs PEMGX (20 years). DBMZX is a more actively managed with annual turnover of: 36.02 vs. PEMGX (10.10). DBMZX (1000) and PEMGX (1000) have matching initial minimum investment requirements. PEMGX (18.67) and DBMZX (18.28) have marching annual gain over last year. PEMGX return over 5 years is better than : 37.53 vs. DBMZX (13.44).
DBMZXPEMGXDBMZX / PEMGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years20 years-
Gain YTD4.6091.549298%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.26B29.3B4%
Annual Yield % from dividends0.000.00-
Returns for 1 year18.2818.6798%
Returns for 3 years2.9918.1516%
Returns for 5 years13.4437.5336%
Returns for 10 years358.76105.29341%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LYEL0.580.02
+2.97%
Lyell Immunopharma
KC9.970.06
+0.61%
Kingsoft Cloud Holdings Limited
BG79.540.14
+0.18%
Bunge Global SA
GENE0.76N/A
N/A
Genetic Technologies Ltd
XENE38.52-1.10
-2.78%
Xenon Pharmaceuticals